Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection
L. Li, Y. Honda-Okubo, Y. Huang, H. Jang, M. A. Carlock, J. Baldwin, S. Piplani, A. G. Bebin-Blackwell, D. Forgacs, K. Sakamoto, A. Stella, S. Turville, T. Chataway, A. Colella, J. Triccas, , N. Petrovsky
This study develops a recombinant SARS-CoV-2 spike protein vaccine, Covax-19, formulated with Advax-SM adjuvant, showing protection against COVID-19 in mice and ferrets.
bioRxiv · Jul 3, 2021Immunology